HR 4007 118th Congress House Health Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Government information and archives

HEAL Act of 2023

Introduced: June 12, 2023 See on congress.gov

Everywhere this bill has been 3 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jun 16, 2023

Referred to the Subcommittee on Health.

Jun 12, 2023

Referred to the House Committee on Energy and Commerce.

Jun 12, 2023

Introduced in House

Plain-English summary Congressional Research Service

Halting the Epidemic of Addiction and Loss Act of 2023 or the HEAL Act of 2023

This bill requires the Department of Health and Human Services (HHS) to ensure that references in its grant programs to opioid overdose reversal agents are inclusive of any such agents that have been approved by the Food and Drug Administration (FDA).

Specifically, HHS must ensure that regulations, guidance, and other documents for grant programs that include references to opioid overdose reversal agents (e.g., naloxone) encompass any opioid overdose reversal agent that has been approved by the FDA. HHS must also update such references with respect to materials that were previously issued for State Opioid Response Grants, Tribal Opioid Response Grants, and Programs of Regional and National Significance for substance use disorder prevention.

What's happening now June 16, 2023

Referred to the Subcommittee on Health.

Committees of jurisdiction 2